Ani pharmaceuticals announces the launch of prochlorperazine maleate tablets usp

Baudette, minn.--(business wire)--ani pharmaceuticals, inc. (“ani” or the “company”) (nasdaq: anip) today announced the launch of prochlorperazine maleate tablets usp, 5 mg and 10 mg. ani's prochlorperazine maleate tablets usp, 5 mg and 10 mg are the generic version of the reference listed drug (rld) compazine® and were developed in technical collaboration with biophore india pharmaceuticals pvt. ltd. (“biophore”). the current annual u.s. market for prochlorperazine maleate tablets usp, 5 mg an
ANIP Ratings Summary
ANIP Quant Ranking